2010s: Tesamorelin research expanded into liver fat, body composition, and metabolic markers
Based on current patent timelines and industry estimates, most projections place potential generic versions of semaglutide in the early-to-mid 2030s at the earliest
Unveiling the neonatal gut microbiota: exploring the influence of delivery mode on early microbial colonization and intervention strategies
The preferred injection sites are in the thigh, abdomen , or upper arm
"I do enjoy food but now my relationship with it is different," Dunham said
Betul Ibis and colleagues, used the TriNetX database to compare 217,302 diabetes patients on GLP-1 medications with 217,302 matched patients on DPP-4 inhibitors. Patients on GLP-1s had a significantly lower risk of developing rheumatoid arthritis (HR = 0.87, p = 0.026), gout, and osteoarthritis within one year